Pharmaceutical

Parkinson’s Trials Must Align With Global Genetic Diversity
Clinical & Pharma Parkinson’s Trials Must Align With Global Genetic Diversity

The rapid evolution of genomic sequencing has unveiled a complex tapestry of Parkinson’s disease drivers, yet the infrastructure for testing these breakthroughs remains tethered to a demographic profile that no longer reflects the global population. As medical science advances, the discrepancy

New GOP Budget Law Slashes the US Social Safety Net
Clinical & Pharma New GOP Budget Law Slashes the US Social Safety Net

As the architecture of the American social welfare system undergoes its most significant restructuring in decades, millions of families are finding themselves standing on increasingly unstable ground. We are joined today by a policy expert who has spent years tracking the intersection of federal

Pharmaceutical Industry Shifts Toward Cruelty-Free Testing
Clinical & Pharma Pharmaceutical Industry Shifts Toward Cruelty-Free Testing

Walking through the brightly lit aisles of a modern American pharmacy often feels like traversing two entirely different moral universes depending on which shelf a customer happens to be browsing. In the personal care and beauty sections, the labels are filled with reassurances about ethical

How Is Asia-Pacific Redefining Healthcare Regulation?
Clinical & Pharma How Is Asia-Pacific Redefining Healthcare Regulation?

The rapid acceleration of medical innovation across the Asia-Pacific region is forcing a fundamental rethink of how governing bodies balance patient safety with the urgent need for advanced technological solutions. Governments in nations like Australia, the Philippines, Japan, and India are

PMNCH Launches Campaign to Fund Women and Children’s Health
Clinical & Pharma PMNCH Launches Campaign to Fund Women and Children’s Health

A staggering decline in international development aid has created a precarious environment for global health, threatening to erase decades of progress achieved in maternal and pediatric care. The Partnership for Maternal, Newborn & Child Health recently introduced an essential two-year global

Who Is Accountable for Opioid Settlement Oversight?
Clinical & Pharma Who Is Accountable for Opioid Settlement Oversight?

Navigating the Multi-Billion Dollar Influx of Opioid Remediation Funds The distribution of fifty-eight billion dollars intended to combat the American addiction crisis marks a historic infusion of capital that could either redefine public health for the next decade or vanish into a labyrinth of

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later